Rabbit anti Human Chromogranin A
X2789P
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetCHGA
Overview
- SupplierNordic-MUbio
- Product NameRabbit anti Human Chromogranin A
- Delivery Days Customer7
- Application Supplier NoteAntibody can be used for immunohistochemistry (1-3 microg/ml) and Western blotting (1-2 microg/ml). Optimal concentration should be evaluated by serial dilutions.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- Applications SupplierWestern Blotting;Immunohistochemistry
- Category SupplierPrimary antibodies
- CertificationResearch Use Only
- ClonalityPolyclonal
- Gene ID1113
- Target nameCHGA
- Target descriptionchromogranin A
- Target synonymsbetagranin (N-terminal fragment of chromogranin A); catestatin; CGA; chromofungin; chromogranin-A; parathyroid secretory protein 1; pituitary secretory protein I; SP-I
- HostRabbit
- Protein IDP10645
- Protein NameChromogranin-A
- Scientific DescriptionSP-1, Pituitary Secretory Protein I
- Shelf life instructionSee expiration date on vial
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteSynthetic peptide derived from human Chromogranin A protein
- UNSPSC12352203
References
- 1. Konecki, D.S., et al. ‘The primary structure of human chromogranin A and pancreastatin’ J. Biol. Chem., 262, 17026-17030 (1987) 2. Pasqua, T., et al. ‘Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts.’ Endocrinology, 154, 3353-3365 (2013) 3. Chen, Y., et al. ‘Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.’ Cell Mol. Neurobiol., 30, 1395-1400 (2010) 4. Mahapatra, N.R., et al. ‘Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.’ J. Clin. Invest., 115, 1942-1952 (2005) 5. Mahata, S.K., et al. ‘Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.’ J. Clin. Invest., 100, 1623-1633 (1997).